This inventor holds 4 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Santen Pharmaceutical Co., Ltd., Boehringer Ingelheim International Gmbh. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011-2026
Title: Koushi Fujisawa: Innovator in Dry Eye Treatment
Introduction
Koushi Fujisawa is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of ophthalmology, particularly in the treatment of dry eye conditions. With a total of 4 patents to his name, Fujisawa's work has the potential to improve the quality of life for many individuals suffering from this common ailment.
Latest Patents
Fujisawa's latest patents focus on a medicament for preventing and/or treating dry eye. One of his key innovations involves a compound that is effective in treating dry eye without substantially impacting intraocular pressure. This medicament includes a method of administering a therapeutically effective amount of olodaterol or a salt thereof to individuals in need. His work emphasizes the importance of providing effective treatment options that do not compromise other aspects of eye health.
Career Highlights
Throughout his career, Koushi Fujisawa has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Santen Pharmaceutical Co., Ltd. and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of eye care.
Collaborations
Fujisawa has collaborated with several professionals in his field, including Kenji Oki and Takashi Nagano. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Koushi Fujisawa's contributions to the treatment of dry eye through his innovative patents highlight his dedication to improving patient care. His work continues to pave the way for advancements in ophthalmology, making a significant impact on the lives of those affected by dry eye conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile